Share
“Civilization begins with distillation,” said William Faulkner, a writer and drinker. Although our thirst for alcohol dates back to the Stone Age, nobody has figured out a good way to deal with the ensuing hangover after getting drunk.
As a chemical engineering professor and wine enthusiast, I felt I needed to find a solution. As frivolous as this project may sound, it has serious implications. Between 8 and 10 percent of emergency room visits in America are due to acute alcohol poisoning. Alcohol is the leading risk factor for premature deaths and disability among people aged 15-49 and its abuse leads to serious health problems, including cardiovascular and liver cancer. Despite these sobering facts, current treatments for alcohol overdose largely rely on the body’s own enzymes to break down this drug.

Yunfeng Lu
Together with professor Cheng Ji, an expert in liver diseases from Keck School of Medicine at the University of Southern California, and my graduate student Duo Xu, we developed an antidote and tested it in mice.
To protect the enzymes, we wrapped each of them in a shell, using a material the U.S. Food and Drug Administration had already approved for pills. We then injected these nanocapsules into the veins of drunk mice where they hurtled through the circulatory system, eventually arriving in the liver where they entered the cells and served as mini–reactors to digest alcohol.
We showed that in inebriated mice (which fall asleep much faster than drunk humans), the treatment decreased the blood alcohol level by 45 percent in just four hours compared to mice that didn’t receive any. Meanwhile, the blood concentration of acetaldehyde – a highly toxic compound that is carcinogenic, causes headaches and vomiting, makes people blush after drinking, and is produced during the normal alcohol metabolism – remained extremely low. The animals given the drug woke from their alcohol-induced slumber faster than their untreated counterparts – something all college students would appreciate.
We are currently completing tests to ensure that our nanocapsules are safe and don’t trigger unexpected or dangerous side effects. If our treatments prove effective in animals, we could begin human clinical trials in as early as one year.

Yunfeng Lu, Professor Chemical and Biomolecular Engineering, University of California, Los Angeles
This article was originally published on The Conversation. Read the original article.
NASA Says 20% of Workforce to Depart Space Agency
1 day ago
Frustration, Gaza Alarm Drove Macron to Go It Alone on Palestine Recognition
1 day ago
Trump Golfs in Scotland as Epstein Questions Persist
1 day ago
Visalia Police Arrest Armed Robbery Suspect at Long John Silver’s
1 day ago
Grand Rising Brings Sober Day Party Vibes to Fresno
1 day ago
Fresno Crash Leaves One Dead After Car Submerges in Canal
1 day ago
‘Jenny from the Block’ Rescued After Camping Out by Calwa ATM
1 day ago
Visalia Police Arrest Wanted Man Following DUI Traffic Stop and Chase
5 hours ago
Categories

Visalia Police Arrest Wanted Man Following DUI Traffic Stop and Chase

Trump, EU’s Von Der Leyen to Meet on Sunday to Clinch Trade Deal

Israel Announces Daily Pauses in Gaza Fighting as Aid Airdrops Begin

NASA Says 20% of Workforce to Depart Space Agency

Frustration, Gaza Alarm Drove Macron to Go It Alone on Palestine Recognition

Trump Golfs in Scotland as Epstein Questions Persist

Visalia Police Arrest Armed Robbery Suspect at Long John Silver’s
